Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Replimune Group, Inc. | 136,110 | reported | 13 Jun 2023 | tx 12+464,083−30,540 |
| Karyopharm Therapeutics Inc. | 59,968 | reported | 25 Feb 2021 | tx 10+171,596−8,687 |
| DiaMedica Therapeutics Inc. | 32,162 | reported | 01 Jun 2025 | tx 4+94,570 |
| VION PHARMACEUTICALS INC | 20,000 | reported | 10 Dec 2008 | tx 1+20,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jun 2025 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 32,162 | 0.00 USD | deriv |
| 01 Jun 2024 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 28,472 | 0.00 USD | deriv |
| 13 Jun 2023 | SALE | Replimune Group, Inc. | 12,043 | 24.10 USD | |
| 13 Jun 2023 | SALE | Replimune Group, Inc. | 817 | 23.45 USD | |
| 01 Jun 2023 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 7,493 | 0.00 USD | deriv |
| 16 May 2023 | SALE | Replimune Group, Inc. | 12,207 | 18.05 USD | |
| 01 Apr 2023 | GRANT_AWARD | Replimune Group, Inc. | 40,000 | 0.00 USD | |
| 01 Apr 2023 | GRANT_AWARD | Replimune Group, Inc. | 60,000 | 0.00 USD | deriv |
| 01 Mar 2023 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 26,443 | 0.00 USD | deriv |
| 16 May 2022 | SALE | Replimune Group, Inc. | 5,473 | 14.59 USD | |
| 01 Apr 2022 | GRANT_AWARD | Replimune Group, Inc. | 52,500 | 0.00 USD | |
| 01 Apr 2022 | GRANT_AWARD | Replimune Group, Inc. | 78,750 | 0.00 USD | deriv |
| 10 May 2021 | GRANT_AWARD | Replimune Group, Inc. | 73,333 | 0.00 USD | |
| 10 May 2021 | GRANT_AWARD | Replimune Group, Inc. | 110,000 | 0.00 USD | deriv |
| 01 Apr 2021 | GRANT_AWARD | Replimune Group, Inc. | 16,500 | 0.00 USD | deriv |
| 25 Feb 2021 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 22,013 | 0.00 USD | |
| 25 Feb 2021 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 59,968 | 0.00 USD | deriv |
| 11 Feb 2021 | SALE | Karyopharm Therapeutics Inc. | 2,046 | 15.52 USD | |
| 05 Feb 2021 | EXERCISE | Karyopharm Therapeutics Inc. | 5,650 | — | |
| 05 Feb 2021 | EXERCISE | Karyopharm Therapeutics Inc. | 5,650 | 0.00 USD | deriv |
| 30 Oct 2020 | SALE | Karyopharm Therapeutics Inc. | 226 | 15.58 USD | |
| 28 Oct 2020 | EXERCISE | Karyopharm Therapeutics Inc. | 765 | — | |
| 28 Oct 2020 | EXERCISE | Karyopharm Therapeutics Inc. | 765 | 0.00 USD | deriv |
| 02 Nov 2020 | GRANT_AWARD | Replimune Group, Inc. | 33,000 | 0.00 USD | deriv |
| 05 Feb 2020 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 60,600 | 0.00 USD | deriv |